SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-001660
Filing Date
2022-01-12
Accepted
2022-01-12 09:41:37
Documents
14
Period of Report
2022-01-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea153897-8k_oramedpharm.htm   iXBRL 8-K 24976
2 PRESS RELEASE DATED JANUARY 12, 2022 ea153897ex99-1_oramedpharm.htm EX-99.1 28337
3 GRAPHIC ex99-1_001.jpg GRAPHIC 1842
  Complete submission text file 0001213900-22-001660.txt   234806

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE ormp-20220112_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ormp-20220112_pre.xml EX-101.PRE 22355
6 XBRL SCHEMA FILE ormp-20220112.xsd EX-101.SCH 3019
8 EXTRACTED XBRL INSTANCE DOCUMENT ea153897-8k_oramedpharm_htm.xml XML 3608
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 22525729
SIC: 2834 Pharmaceutical Preparations